Cited by 4,221Advanced Glycation End Products researchImmune Response and InflammationCell death mechanisms and regulation

The DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index.

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

Scaffidi, Paola, Misteli, Tom, Bianchi, Marco E.·2002·Nature

DOI 10.1038/nature00858

Open this paper in CoChat — free account

Abstract

High mobility group 1 (HMGB1) protein is both a nuclear factor and a secreted protein. In the cell nucleus it acts as an architectural chromatin-binding factor that bends DNA and promotes protein assembly on specific DNA targets. Outside the cell, it binds with high affinity to RAGE (the receptor for advanced glycation end products) and is a potent mediator of inflammation. HMGB1 is secreted by activated monocytes and macrophages, and is passively released by necrotic or damaged cells. Here we report that Hmgb1(-/-) necrotic cells have a greatly reduced ability to promote inflammation, which proves that the release of HMGB1 can signal the demise of a cell to its neighbours. Apoptotic cells do not release HMGB1 even after undergoing secondary necrosis and partial autolysis, and thus fail to promote inflammation even if not cleared promptly by phagocytic cells. In apoptotic cells, HMGB1 is bound firmly to chromatin because of generalized underacetylation of histone and is released in the extracellular medium (promoting inflammation) if chromatin deacetylation is prevented. Thus, cells undergoing apoptosis are programmed to withhold the signal that is broadcast by cells that have been damaged or killed by trauma.

Integrity signals

Registry

Crossref · 10.1038/nature00858

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L. V., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,386
A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A., & Nagata, S. (1998) · Nature · doi:10.1038/34112 · Cited by 3,239
High Mobility Group 1 Protein (Hmg-1) Stimulates Proinflammatory Cytokine Synthesis in Human Monocytes
Andersson, U., Wang, H., Palmblad, K., Aveberger, A.-C., Bloom, O., Erlandsson-Harris, H., Janson, A., Kokkola, R., Zhang, M., Yang, H., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.565 · Cited by 1,401
High mobility of proteins in the mammalian cell nucleus
Phair, R. D., & Misteli, T. (2000) · Nature · doi:10.1038/35007077 · Cited by 1,217
Self-citation
Phagocytosis and clearance of apoptotic cells is mediated by MER
Scott, R. S., McMahon, E. J., Pop, S. M., Reap, E. A., Caricchio, R., Cohen, P. L., Earp, H. S., & Matsushima, G. K. (2001) · Nature · doi:10.1038/35075603 · Cited by 1,215
The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin
Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., Nitecki, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25752 · Cited by 1,151
Regulation of DNA-Dependent Activities by the Functional Motifs of the High-Mobility-Group Chromosomal Proteins
Bustin, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5237 · Cited by 848
Cutting Edge: HMG-1 as a Mediator of Acute Lung Inflammation
Abraham, E. H., Arcaroli, J. J., Carmody, A., Wang, H., & Tracey, K. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.2950 · Cited by 692
Dynamic binding of histone H1 to chromatin in living cells
Misteli, T., Gunjan, A., Hock, R., Bustin, M., & Brown, D. T. (2000) · Nature · doi:10.1038/35048610 · Cited by 658
Self-citation
The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice
Calogero, S., Grassi, F., Aguzzi, A., Voigtländer, T., Ferrier, P., Ferrari, S., & Bianchi, M. E. (1999) · Nature Genetics · doi:10.1038/10338 · Cited by 528
Self-citation

Flagged first, then by citations

Show all 26 references

1 of the 26 references couldn’t be matched to a known paper.

Sorted by citations

Items 601–700 of 1,019

A novel real time imaging platform to quantify macrophage phagocytosis
Kapellos, T. S., Taylor, L., Lee, H., Cowley, S. A., James, W. S., Iqbal, A. J., & Greaves, D. R. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.07.011 · Cited by 148
Innate immunity as a target for acute cardioprotection
Zuurbier, C. J., Abbate, A., Cabrera-Fuentes, H. A., Cohen, M. V., Collino, M., de Kleijn, D. P. V., Downey, J. M., Pagliaro, P., Preissner, K. T., Takahashi, M., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy304 · Cited by 149
HMGB1, a novel inflammatory cytokine
Yamada, S., & Maruyama, I. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.07.019 · Cited by 146
Contribution of High-Mobility Group Box-1 to the Development of Ventilator-induced Lung Injury
Ogawa, E. N., Ishizaka, A., Tasaka, S., Koh, H., Ueno, H., Amaya, F., Ebina, M., Yamada, S., Funakoshi, Y., Soejima, J., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200605-699oc · Cited by 146
Signalling via the Osteopontin and High Mobility Group Box-1 Axis Drives the Fibrogenic Response to Liver Injury
Arriazu, E., Ge, X., Leung, T.-M., Magdaleno, F., Lopategi, A., Lu, Y., Kitamura, N., Urtasun, R., Theise, N., Antoine, D. J., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-310752 · Cited by 144
Dendritic Cells and Damage-Associated Molecular Patterns: Endogenous Danger Signals Linking Innate and Adaptive Immunity
Nace, G., Evankovich, J. W., Eid, R. E., & Tsung, A. (2011) · Journal of Innate Immunity · doi:10.1159/000334245 · Cited by 149
DAMPs, ageing, and cancer: The ‘DAMP Hypothesis’
Huang, J., Xie, Y., Sun, X., Zeh, H. J., Kang, R., Lotze, M. T., & Tang, D. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2014.10.004 · Cited by 144
Danger‐associated molecular patterns ( DAMPs ) in acute lung injury
Tolle, L. B., & Standiford, T. J. (2013) · The Journal of Pathology · doi:10.1002/path.4124 · Cited by 157
Interleukin-1 Stimulates β-Cell Necrosis and Release of the Immunological Adjuvant HMGB1
Steer, S. A., Scarim, A. L., Chambers, K. T., & Corbett, J. A. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0030017 · Cited by 144
Proteomic identification of multitasking proteins in unexpected locations complicates drug targeting
Butler, G. S., & Overall, C. M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2945 · Cited by 144
The danger within: endogenous danger signals, atopy and asthma
Willart, M. A. M., & Lambrecht, B. N. (2008) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2008.03118.x · Cited by 144
Cell death in chronic inflammation: breaking the cycle to treat rheumatic disease
Anderton, H., Wicks, I. P., & Silke, J. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0455-8 · Cited by 152
High-mobility group box family of proteins: ligand and sensor for innate immunity
Yanai, H., Ban, T., & Taniguchi, T. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.10.005 · Cited by 146
Targeting HMGB1 in the treatment of sepsis
Wang, H., Ward, M. F., & Sama, A. E. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.863876 · Cited by 144
High-Mobility Group Box Protein 1 Neutralization Reduces Development of Diet-Induced Atherosclerosis in Apolipoprotein E–Deficient Mice
Kanellakis, P., Agrotis, A., Kyaw, T. S., Koulis, C., Ahrens, I., Mori, S., Takahashi, H. K., Liu, K., Peter, K., Nishibori, M., et al. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.218669 · Cited by 144
High Mobility Group Box 1 (HMGB1) Activates an Autophagic Response to Oxidative Stress
Tang, D., Kang, R., Livesey, K. M., Zeh, H. J., & Lotze, M. T. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3666 · Cited by 146
Induction of Abscopal Anti-Tumor Immunity and Immunogenic Tumor Cell Death by Ionizing Irradiation - Implications for Cancer Therapies
Frey, B., Rubner, Y., Wunderlich, R., Weiss, E., Pockley, A. G., Fietkau, R., & Gaipl, U. S. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800099811 · Cited by 149
Mechanisms linking bacterial infections of the bovine endometrium to disease and infertility
Carneiro, L. C., Cronin, J., & Sheldon, I. M. (2015) · Reproductive Biology · doi:10.1016/j.repbio.2015.12.002 · Cited by 154
Sepsis and disseminated intravascular coagulation
Okamoto, K., Tamura, T., & Sawatsubashi, Y. (2016) · Journal of Intensive Care · doi:10.1186/s40560-016-0149-0 · Cited by 148
The Janus face of HMGB1 in heart disease: a necessary update
Raucci, A., Maggio, S. D., Scavello, F., D’Ambrosio, A., Bianchi, M. E., & Capogrossi, M. C. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2930-9 · Cited by 144
Self-citation
DCN released from ferroptotic cells ignites AGER-dependent immune responses
Liu, J., Zhu, S., Zeng, L., Li, J., Klionsky, D. J., Kroemer, G., Jiang, J., Tang, D., & Kang, R. (2021) · Autophagy · doi:10.1080/15548627.2021.2008692 · Cited by 150
“occurs in various cell death modalities, including apoptosis [10], necrosis [11], pyroptosis [12], and ferroptosis [13].”
Background
High-mobility group box 1 is involved in the initial events of early loss of transplanted islets in mice
Matsuoka, N., Itoh, T., Watarai, H., Sekine-Kondo, E., Nagata, N., Okamoto, K., Mera, T., Yamamoto, H., Yamada, S., Maruyama, I., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41360 · Cited by 142
Activation of Human Umbilical Vein Endothelial Cells Leads to Relocation and Release of High‐Mobility Group Box Chromosomal Protein 1
Mullins, G. E., Sundén‐Cullberg, J., Johansson, A., Rouhiainen, A., Erlandsson-Harris, H., Yang, H., Tracey, K. J., Rauvala, H., Palmblad, J. E. W., Andersson, J., et al. (2004) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2004.01518.x · Cited by 142
The Alarmin HMGB1 Mediates Age-Induced Neuroinflammatory Priming
Fonken, L. K., Frank, M. G., Kitt, M. M., D'Angelo, H. M., Norden, D. M., Weber, M. D., Barrientos, R. M., Godbout, J. P., Watkins, L. R., & Maier, S. F. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.1161-16.2016 · Cited by 139
TLR2, TLR4 and the MYD88 Signaling Pathway Are Crucial for Neutrophil Migration in Acute Kidney Injury Induced by Sepsis
Castoldi, Â., Braga, T. T., Corrêa-Costa, M., de Aguiar, C. F., Bassi, Ê. J., Correa-Silva, R., Elias, R. M., Salvador, F. A., Moraes‐Vieira, P. M., Cenedeze, M. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037584 · Cited by 144
Necrotic cell death in atherosclerosis
Martinet, W., Schrijvers, D. M., & Meyer, G. R. Y. D. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0192-x · Cited by 139
HMGB1: a two-headed signal regulating tumor progression and immunity
Campana, L., Bosurgi, L., & Rovere, P. Q. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.04.012 · Cited by 142
Early release of high-mobility group box 1 (HMGB1) from neurons in experimental subarachnoid hemorrhage in vivo and in vitro
Sun, Q., Wu, W., Hu, Y.-C., Li, H., Zhang, D.-D., Li, S., Li, W., Li, W.-D., Ma, B., Zhu, J., et al. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-106 · Cited by 141
Post-Infarction Inflammation and Left Ventricular Remodeling
Anzai, T. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-0013 · Cited by 142
HMGB1 upregulates NF-kB by inhibiting IKB-α and associates with diabetic retinopathy
Liang, W., Yang, H., Liu, H., Qian, W., & Chen, X. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117146 · Cited by 141
Differential effects between amphoterin and advanced glycation end products on colon cancer cells
Kuniyasu, H., Chihara, Y., & Kondo, H. (2003) · International Journal of Cancer · doi:10.1002/ijc.11016 · Cited by 141
Active relocation of chromatin and endoplasmic reticulum into blebs in late apoptotic cells
Lane, J. D., Allan, V., & Woodman, P. G. (2005) · Journal of Cell Science · doi:10.1242/jcs.02529 · Cited by 141
Autophagy and Liver Ischemia-Reperfusion Injury
Cursio, R., Colosetti, P., & Gugenheim, J. (2015) · BioMed Research International · doi:10.1155/2015/417590 · Cited by 142
The Nuclear Factor κB pathway: A link to the immune system in the radiation response
Hellweg, C. E. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.02.019 · Cited by 143
Regulation of wound healing and organ fibrosis by toll-like receptors
Huebener, P., & Schwabe, R. F. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.11.017 · Cited by 140
Activated protein C inhibits high mobility group box 1 signaling in endothelial cells
Bae, J., & Rezaie, A. R. (2011) · Blood · doi:10.1182/blood-2011-06-360701 · Cited by 140
Stress-induced cellular responses in immunogenic cell death: Implications for cancer immunotherapy
Radogna, F., & Diederich, M. F. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.02.006 · Cited by 146
Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus
Popovic, K., Ek, M., Espinosa, A., Padyukov, L., Harris, H. E., Wahren‐Herlenius, M., & Nyberg, F. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21398 · Cited by 140
The mechanism of cell death during West Nile virus infection is dependent on initial infectious dose
Chu, J. J. H., & Ng, M. L. (2003) · Journal of General Virology · doi:10.1099/vir.0.19447-0 · Cited by 140
Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke
Hayakawa, K., Qiu, J., & Lo, E. H. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05728.x · Cited by 144
Improved Clinical Outcome in Indolent B-Cell Lymphoma Patients Vaccinated with Autologous Tumor Cells Experiencing Immunogenic Death
Zappasodi, R., Pupa, S. M., Ghedini, G. C., Bongarzone, I., Magni, M., Cabras, A. D., Colombo, M. P., Carlo‐Stella, C., Gianni, A. M., & Nicola, M. D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1825 · Cited by 149
Mechanisms of Translocation of ER Chaperones to the Cell Surface and Immunomodulatory Roles in Cancer and Autoimmunity
Wiersma, V. R., Michalak, M., Abdullah, T. M., Bremer, E., & Eggleton, P. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00007 · Cited by 147
Enhancing photodynamic therapy of refractory solid cancers: Combining second-generation photosensitizers with multi-targeted liposomal delivery
Weijer, R., Broekgaarden, M., Kos, M., van Vught, R., Rauws, E. A., Breukink, E. J., van Gulik, T. M., Storm, G., & Heger, M. (2015) · Journal of Photochemistry and Photobiology C Photochemistry Reviews · doi:10.1016/j.jphotochemrev.2015.05.002 · Cited by 141
A core viral protein binds host nucleosomes to sequester immune danger signals
Avgousti, D. C., Herrmann, C., Kulej, K., Pancholi, N. J., Sekulić, N., Petrescu, J., Molden, R. C., Blumenthal, D., Paris, A. J., Reyes, E. D., et al. (2016) · Nature · doi:10.1038/nature18317 · Cited by 139
Chemotherapeutic drug-induced immunogenic cell death for nanomedicine-based cancer chemo–immunotherapy
Jiang, M., Zeng, J., Zhao, L., Zhang, M., Ma, J., Guan, X., & Zhang, W. (2021) · Nanoscale · doi:10.1039/d1nr05512g · Cited by 145
HMGB-1 AS A THERAPEUTIC TARGET FOR INFECTIOUS AND INFLAMMATORY DISORDERS
Mantell, L. L., Parrish, W. R., & Ulloa, L. (2005) · Shock · doi:10.1097/01.shk.0000188710.04777.9e · Cited by 140
Recombinant HMGB1 with cytokine-stimulating activity.
Li, J.-H., Wang, H., Mason, J. M., Levine, J., Yu, M., Ulloa, L., Czura, C., Tracey, K., & Yang, H. (2004) · JIM - Journal of Immunological Methods · doi:10.1016/j.jim.2004.04.019 · Cited by 142
Ischemia/reperfusion activates myocardial innate immune response: the key role of the toll-like receptor
Vilahur, G., & Badimón, L. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00496 · Cited by 138
Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients
Yan, X. X., Lu, L., Peng, W. H., Wang, L. J., Zhang, Q., Zhang, R., Chen, Q., & Shen, W. F. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.12.016 · Cited by 138
Autophagy modulation for cancer therapy
Yang, Z. J., Chee, C. E., Huang, S., & Sinicrope, F. A. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.2.14663 · Cited by 140
Regulation of Programmed Cell Death by NF-κB and its Role in Tumorigenesis and Therapy
Fan, Y., Dutta, J., Gupta, N., Fan, G., & Gélinas, C. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-1-4020-6554-5_11 · Cited by 137
Further characterization of high mobility group box 1 (HMGB1) as a proinflammatory cytokine: central nervous system effects
O’Connor, K., Hansen, M. K., Pugh, C., Deak, M. M., Biedenkapp, J. C., Milligan, E. D., Johnson, J. D., Wang, H., Maier, S. F., Tracey, K. J., et al. (2003) · Cytokine · doi:10.1016/j.cyto.2003.08.001 · Cited by 138
Hyperoxia-induced signal transduction pathways in pulmonary epithelial cells
Zaher, T. E., Miller, E. J., Morrow, D. M. P., Javdan, M., & Mantell, L. L. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.01.021 · Cited by 138
Evidence for Involvement of HMGB1 Protein in Human DNA Mismatch Repair
Yuan, F., Gu, L., Guo, S., Wang, C., & Li, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401931200 · Cited by 140
Necrosis in yeast
Eisenberg, T., Carmona‐Gutiérrez, D., Büttner, S., Tavernarakis, N., & Madeo, F. (2010) · APOPTOSIS · doi:10.1007/s10495-009-0453-4 · Cited by 141
A small molecule binding HMGB1 and HMGB2 inhibits microglia-mediated neuroinflammation
Lee, S., Nam, Y., Koo, J. Y., Lim, D., Park, J., Ock, J., Kim, J., Suk, K., & Park, S. B. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1669 · Cited by 139
High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts
Wähämaa, H., Schierbeck, H., Hreggvidsdottir, H. S., Palmblad, K., Aveberger, A.-C., Andersson, U., & Harris, H. E. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3450 · Cited by 138
Association of Chromatin Proteins High Mobility Group Box (HMGB) 1 and HMGB2 with Mitotic Chromosomes
Pallier, C., Scaffidi, P., Chopineau-Proust, S., Agresti, A., Nordmann, P., Bianchi, M. E., & Maréchal, V. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-09-0581 · Cited by 137
Self-citation
Tumor Eradication by Cisplatin Is Sustained by CD80/86-Mediated Costimulation of CD8+ T Cells
Nejad, E. B., van der Sluis, T. C., van Duikeren, S., Yagita∥, H., Janssen, G. M. C., van Veelen, P. A., Melief, C. J. M., van der Burg, S. H., & Arens, R. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0881 · Cited by 137
Expression and regulation of interleukin‐33 in human monocytes
Nile, C. J., Barksby, E., Jitprasertwong, P., Preshaw, P. M., & Taylor, J. J. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03221.x · Cited by 145
Neural regulators of innate immune responses and inflammation
Pavlov, V. A., & Tracey, K. J. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4102-3 · Cited by 174
High-mobility group box 1 is a novel deacetylation target of Sirtuin1
Rabadi, M. M., Xavier, S., Vasko, R., Kaur, K., Goligorksy, M. S., & Ratliff, B. B. (2014) · Kidney International · doi:10.1038/ki.2014.217 · Cited by 137
Minocycline prevents the depressive-like behavior through inhibiting the release of HMGB1 from microglia and neurons
Wang, B., Huang, X., Pan, X., Zhang, T., Hou, C., Su, W., Liu, L.-L., Li, J., & Wang, Y. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.06.019 · Cited by 134
Innate Immunity and Biomaterials at the Nexus: Friends or Foes
Christo, S. N., Diener, K. R., Bachhuka, A., Vasilev, K. A., & Hayball, J. D. (2015) · BioMed Research International · doi:10.1155/2015/342304 · Cited by 138
Neutrophil-mediated tumour angiogenesis: Subversion of immune responses to promote tumour growth
Tazzyman, S. J., Niaz, H. A., & Murdoch, C. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.02.003 · Cited by 138
The expression of HMGB1 protein and its receptor RAGE in human malignant tumors
Kostova, N. N., Zlateva, S., Ugrinova, I., & Pasheva, E. A. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0305-0 · Cited by 135
The role of high mobility group box 1 (HMGB1) in the pathogenesis of kidney diseases
Chen, Q., Guan, X., Zuo, X., Wang, J., & Yin, W. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.02.004 · Cited by 137
Neuroinflammation in neurological disorders: pharmacotherapeutic targets from bench to bedside
Mishra, A., Bandopadhyay, R., Singh, P. K., Mishra, P. S., Sharma, N., & Khurana, N. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00806-4 · Cited by 134
“It has been reported that immediately after neuronal injury, the amount of HMGB1 in the neuronal extracellular space gets increased several folds (Scaffidi et al. 2002).”
Background
The Relationship between Apoptosis and High-Mobility Group Protein 1 Release from Murine Macrophages Stimulated with Lipopolysaccharide or Polyinosinic-Polycytidylic Acid
Jiang, W., Bell, C. W., & Pisetsky, D. S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.10.6495 · Cited by 134
Insights from Mendelian Interferonopathies: Comparison of CANDLE, SAVI with AGS, Monogenic Lupus
Kim, H., Sanchez, G. A. M., & Goldbach‐Mansky, R. T. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1465-5 · Cited by 137
The Anti-inflammatory Effects of Heat Shock Protein 72 Involve Inhibition of High-Mobility-Group Box 1 Release and Proinflammatory Function in Macrophages
Tang, D., Kang, R., Xiao, W., Wang, H., Calderwood, S. K., & Xiao, X. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.2.1236 · Cited by 134
Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice
Sitia, G., Iannacone, M., Müller, S., Bianchi, M. E., & Guidotti, L. G. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306173 · Cited by 134
Self-citation
Toll-like receptors, wound healing, and carcinogenesis
Kluwe, J., Mencin, A. M., & Schwabe, R. F. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0426-z · Cited by 137
Detection of immune danger signals by NALP3
Martinon, F. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0607362 · Cited by 140
Tempering the wrath of RAGE: An emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation
Yan, S. F., Yan, S. D., Ramasamy, R., & Schmidt, A. M. (2009) · Annals of Medicine · doi:10.1080/07853890902806576 · Cited by 135
Targeting levels or oligomerization of nucleophosmin 1 induces differentiation and loss of survival of human AML cells with mutant NPM1
Balusu, R., Fiskus, W. C., Rao, R., Chong, D. G., Nalluri, S., Mudunuru, U., Ma, H., Chen, L., Venkannagari, S., Ha, K., et al. (2011) · Blood · doi:10.1182/blood-2010-09-309674 · Cited by 131
Concepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapies
Gebremeskel, S., & Johnston, B. (2015) · Oncotarget · doi:10.18632/oncotarget.6113 · Cited by 139
Regulation of Posttranslational Modifications of HMGB1 During Immune Responses
Tang, Y., Zhao, X. S., Antoine, D. J., Xiao, X., Wang, H., Andersson, U., Billiar, T. R., Tracey, K. J., & Lü, B. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6409 · Cited by 132
Staphylococcus aureus Leukocidin A/B (LukAB) Kills Human Monocytes via Host NLRP3 and ASC when Extracellular, but Not Intracellular
Melehani, J. H., James, D. B. A., Dumont, A., Torres, V. J., & Duncan, J. A. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004970 · Cited by 135
Blockade of high mobility group box-1 protein attenuates experimental severe acute pancreatitis
Sawa, H. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i47.7666 · Cited by 132
Endogenous IL-33 enhances Th2 cytokine production and T-cell responses during allergic airway inflammation
Louten, J., Rankin, A. L., Li, Y., Murphy, E. E., Beaumont, M., Moon, C., Bourne, P. A., McClanahan, T. K., Pflanz, S., & Malefyt, R. D. W. (2011) · International Immunology · doi:10.1093/intimm/dxr006 · Cited by 132
Preferential Cytotoxicity of Bortezomib toward Hypoxic Tumor Cells via Overactivation of Endoplasmic Reticulum Stress Pathways
Fels, D. R., Ye, J., Segan, A. T., Kridel, S. J., Spiotto, M. T., Olson, M., Koong, A. C., & Koumenis, C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2873 · Cited by 132
Chapter 16 Methods for Distinguishing Apoptotic from Necrotic Cells and Measuring Their Clearance
Krysko, D. V., Berghe, T. V., Parthoens, E., D'Herde, K. G. M. A., & Vandenabeele, P. (2008) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(08)01416-x · Cited by 132
HMGB1 as a cytokine and therapeutic target
Yang, H., Wang, H., Czura, C. J., & Tracey, K. J. (2002) · Journal of Endotoxin Research · doi:10.1179/096805102125001091 · Cited by 132
Selective Proinflammatory Activation of Astrocytes by High-Mobility Group Box 1 Protein Signaling
Pedrazzi, M., Patrone, M., Passalacqua, M., Ranzato, E., Colamassaro, D., Sparatore, B., Pontremoli, S., & Melloni, E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.12.8525 · Cited by 132
HMGB1 inhibitor glycyrrhizin attenuates intracerebral hemorrhage-induced injury in rats
Ohnishi, M., Katsuki, H., Fukutomi, C., Takahashi, M., Motomura, M., Fukunaga, M., Matsuoka, Y., Isohama, Y., Izumi, Y., Kume, T., et al. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.06.026 · Cited by 131
Development of hybrid small molecules that induce degradation of estrogen receptor‐alpha and necrotic cell death in breast cancer cells
Okuhira, K., Demizu, Y., Hattori, T., Ohoka, N., Shibata, N., Nishimaki‐Mogami, T., Okuda, H., Kurihara, M., & Naito, M. (2013) · Cancer Science · doi:10.1111/cas.12272 · Cited by 132
HMGB1 activates nuclear factor-κB signaling by RAGE and increases the production of TNF-α in human umbilical vein endothelial cells
Luan, Z., Zhang, H., Yang, P., Ma, X., Zhang, C., & Guo, R.-X. (2010) · Immunobiology · doi:10.1016/j.imbio.2009.11.001 · Cited by 132
Clusterin facilitates apoptotic cell clearance and prevents apoptotic cell-induced autoimmune responses
Cunin, P., Beauvillain, C., Miot, C., Augusto, J., Preisser, L., Blanchard, S., Pignon, P., Scotet, M., Garo, E., Frémaux, I., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.113 · Cited by 132
Targeting HMGB1 for the treatment of sepsis and sepsis-induced organ injury
Deng, C., Zhao, L., Yang, Z. P., Shang, J., Wang, C., Shen, M., Jiang, S., Tian, L., Di, W., Chen, Y., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00676-7 · Cited by 139
Acetaminophen-induced hepatic neutrophil accumulation and inflammatory liver injury in CD18-deficient mice
Williams, C. D., Bajt, M. L., Farhood, A. I., & Jaeschke, H. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02284.x · Cited by 130
Emerging Role of High-Mobility Group Box 1 (HMGB1) in Liver Diseases
Chen, R., Hou, W., Zhang, Q., Kang, R., Fan, X., & Tang, D. (2013) · Molecular Medicine · doi:10.2119/molmed.2013.00099 · Cited by 130
Extracellular high mobility group box chromosomal protein 1 is a coupling factor for hypoxia and inflammation in arthritis
Hamada, T., Torikai, M., Kuwazuru, A., Tanaka, M., Horai, N., Fukuda, T., Yamada, S., Nagayama, S., Hashiguchi, K., Sunahara, N., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23729 · Cited by 130
HMGB1 as a Key Mediator of Immune Mechanisms in Ischemic Stroke
Singh, V., Roth, S., Veltkamp, R. C., & Liesz, A. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6397 · Cited by 130
Myocardial Infarction Primes Autoreactive T Cells through Activation of Dendritic Cells
der Borght, K. V., Scott, C. L., Nindl, V., Bouché, A., Martens, L., Sichien, D., Moorleghem, J. V., Vanheerswynghels, M., Prijck, S. D., Saeys, Y., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.079 · Cited by 131
A small-molecule allosteric inhibitor of BAX protects against doxorubicin-induced cardiomyopathy
Amgalan, D., Garner, T. P., Pekson, R., Jia, X. F., Yanamandala, M., Paulino, V. M., Liang, F. G., Corbalan, J. J., Lee, J., Chen, Y., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0039-1 · Cited by 132
Mechanisms of Regulated Cell Death: Current Perspectives
Santagostino, S. F., Assenmacher, C., Tarrant, J. C., Adedeji, A. O., & Radaelli, E. (2021) · Veterinary Pathology · doi:10.1177/03009858211005537 · Cited by 137
Bench-to-bedside review: The inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis
Bopp, C., Bierhaus, A., Hofer, S., Bouchon, A., Nawroth, P. P., Martin, E., & Weigand, M. A. (2007) · Critical Care · doi:10.1186/cc6164 · Cited by 131
Emerging Roles for HMGB1 Protein in Immunity, Inflammation, and Cancer
Ranzato, E., Martinotti, S., & Patrone, M. (2015) · ImmunoTargets and Therapy · doi:10.2147/itt.s58064 · Cited by 127
Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice
Gu, Z., Akiyama, K., Ma, X., Zhang, H., Feng, X., Yao, G., Hou, Y., Lu, L., Gilkeson, G., Silver, R. M., et al. (2010) · Lupus · doi:10.1177/0961203310373782 · Cited by 130

Authors: Scaffidi, P., Misteli, T., & Bianchi, M. E.
Affiliations: National Institutes of Health (US)
Vita-Salute San Raffaele University (IT)
Corresponding author: Bianchi, Marco E.
ORCID: Scaffidi, Paola
Misteli, Tom
Bianchi, Marco E.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2002-07-11
Volume: 418
Issue: 6894
Pages: 191-195
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature00858
OpenAlex: W2004266769
Cited by: 4,221
References: 26
Citations by year: 2026: 104 · 2025: 106 · 2024: 129 · 2023: 158 · 2022: 168 · 2021: 233 · 2020: 204 · 2019: 196 · 2018: 211 · 2017: 205 · 2016: 228 · 2015: 253 · 2014: 276 · 2013: 261 · 2012: 230
FWCI: 47.06
Type: journal article
Language: en
Update notices: erratum (2010-09-30)
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords: HMGB1, necrosis, apoptosis, inflammation, chromatin, histone acetylation, RAGE, extracellular HMGB1 release, secondary necrosis, phagocytosis, damage-associated molecular patterns
MeSH terms: Acetylation, Animals, Cell Survival, Chromatin, HeLa Cells, Humans, Inflammation, Necrosis, Protein Binding, Apoptosis, Gene Deletion, HMGB1 Protein, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks